News - Sagent Pharmaceuticals

Filter

Current filters:

Sagent Pharmaceuticals

Popular Filters

Sagent Pharma debuts Carboplatin Injection

Sagent Pharma debuts Carboplatin Injection

04-11-2013

US specialty drugmaker Sagent Pharmaceuticals has announced the launch of Carboplatin Injection, an antineoplastic…

Asia-PacificCarboplatinMarkets & MarketingNorth AmericaOncologyPharmaceuticalProductionSagent Pharmaceuticals

Sagent Pharma expands voluntary withdrawal of vecuronium inj vials

13-06-2013

US drugmaker Sagent Pharmaceuticals (Nasdaq: SGNT) said today (June 13) that it is expanding its voluntary…

GenericsMarkets & MarketingMustafa Nevzat PharmaNeurologicalNorth AmericaSagent Pharmaceuticalsvecuronium bromide

Sagent Pharma to buy remaining 50% stake in Chinese JV for $25 million

06-05-2013

US specialty pharmaceutical company Sagent Pharmaceuticals (Nasdaq: SGNT) has entered into an agreement…

Asia-PacificGenericsKanghong Sagent (Chengdu) PharmaceuticalMergers & AcquisitionsPharmaceuticalProductionSagent Pharmaceuticals

Sagent Pharma launches generic Zometa in USA; amends supply deal with Actavis

07-03-2013

Privately-held US specialty pharmaceutical company Sagent Pharmaceuticals has announced the approval…

ActavisGenericsMarkets & MarketingNorth AmericaNovartisOncologyProductionSagent PharmaceuticalsZometa

Back to top